PRESS RELEASE – Lund, February 11th, 2026 – Monthly investor meeting on the 13th of February when Hamlet BioPharma is releasing it’s Q2 report

Hamlet BioPharma invites you to our February investors’ meeting to be held on the 13th of February 2026, at 12:00.

Please click on the link below to participate in the meeting

https://youtube.com/live/qstpMe2jhKI?feature=share

For more information, please contact:

Catharina Svanborg, Chair of the Board, Hamlet BioPharma, +46-709 42 65 49

catharina.svanborg@hamletpharma.com

Jakob Testad, CEO, Hamlet BioPharma, +46-708 48  42 10

jakob.testad@hamletbiopharma.com